相似文献
1
IBD: Patients with IBD find symptom relief in the Cannabis field.
Nat Rev Gastroenterol Hepatol. 2014 Mar;11(3):142-3. doi: 10.1038/nrgastro.2013.245. Epub 2013 Dec 24.
2
Cannabis use amongst patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c.
3
Marijuana use patterns among patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2013 Dec;19(13):2809-14. doi: 10.1097/01.MIB.0000435851.94391.37.
4
Attitudes towards and use of cannabis in New Zealand patients with inflammatory bowel disease: an exploratory study.
N Z Med J. 2021 Feb 19;134(1530):38-47.
5
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn's disease.
Inflamm Bowel Dis. 2014 Mar;20(3):472-80. doi: 10.1097/01.MIB.0000440982.79036.d6.
6
Legalization of Medicinal Marijuana Has Minimal Impact on Use Patterns in Patients With Inflammatory Bowel Disease.
Inflamm Bowel Dis. 2018 Oct 12;24(11):2309-2314. doi: 10.1093/ibd/izy141.
7
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.
Digestion. 2012;85(1):1-8. doi: 10.1159/000332079. Epub 2011 Nov 17.
8
Cannabis, Cannabinoids, and the Endocannabinoid System-Is there Therapeutic Potential for Inflammatory Bowel Disease?
J Crohns Colitis. 2019 Mar 30;13(4):525-535. doi: 10.1093/ecco-jcc/jjy185.
9
Cannabis, a potential treatment option in pediatric IBD? Still a long way to go.
Expert Rev Clin Pharmacol. 2019 Apr;12(4):355-361. doi: 10.1080/17512433.2019.1582330. Epub 2019 Feb 26.
10
An overview of cannabis based treatment in Crohn's disease.
Expert Rev Gastroenterol Hepatol. 2020 Apr;14(4):253-257. doi: 10.1080/17474124.2020.1740590. Epub 2020 Mar 12.
引用本文的文献
1
Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.
Front Immunol. 2021 Dec 22;12:790803. doi: 10.3389/fimmu.2021.790803. eCollection 2021.
2
Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.
Cannabis Cannabinoid Res. 2022 Aug;7(4):445-450. doi: 10.1089/can.2020.0155. Epub 2021 Mar 24.
3
Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options.
Neuronal Signal. 2018 Nov 2;2(4):NS20170144. doi: 10.1042/NS20170144. eCollection 2018 Dec.
4
Modulation of the Endocannabinoid System Following Central Nervous System Injury.
Int J Mol Sci. 2019 Jan 17;20(2):388. doi: 10.3390/ijms20020388.
5
QingBai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-κB signalling.
Cell Prolif. 2019 Mar;52(2):e12547. doi: 10.1111/cpr.12547. Epub 2019 Jan 18.
6
Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock.
Metabolites. 2017 Nov 1;7(4):55. doi: 10.3390/metabo7040055.
7
Therapeutic Use of Cannabis in Inflammatory Bowel Disease.
Gastroenterol Hepatol (N Y). 2016 Nov;12(11):668-679.
8
Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.
J Pediatr Gastroenterol Nutr. 2017 Feb;64(2):265-271. doi: 10.1097/MPG.0000000000001393.
本文引用的文献
1
Marijuana use patterns among patients with inflammatory bowel disease.
Inflamm Bowel Dis. 2013 Dec;19(13):2809-14. doi: 10.1097/01.MIB.0000435851.94391.37.
2
Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.
Clin Gastroenterol Hepatol. 2013 Oct;11(10):1276-1280.e1. doi: 10.1016/j.cgh.2013.04.034. Epub 2013 May 4.
3
A potential role for GPR55 in gastrointestinal functions.
Curr Opin Pharmacol. 2012 Dec;12(6):653-8. doi: 10.1016/j.coph.2012.09.009. Epub 2012 Oct 10.
4
The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.
Trends Mol Med. 2012 Oct;18(10):615-25. doi: 10.1016/j.molmed.2012.07.009. Epub 2012 Aug 21.
5
A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.
Am J Gastroenterol. 2012 Sep;107(9):1399-406. doi: 10.1038/ajg.2012.196. Epub 2012 Jul 10.
6
Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.
Digestion. 2012;85(1):1-8. doi: 10.1159/000332079. Epub 2011 Nov 17.
7
Cannabis use amongst patients with inflammatory bowel disease.
Eur J Gastroenterol Hepatol. 2011 Oct;23(10):891-6. doi: 10.1097/MEG.0b013e328349bb4c.
8
The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.
Mucosal Immunol. 2011 Sep;4(5):574-83. doi: 10.1038/mi.2011.18. Epub 2011 Apr 6.
9
Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue.
PLoS One. 2009 Sep 4;4(9):e6893. doi: 10.1371/journal.pone.0006893.
10
Pharmacological actions of cannabinoids.
Handb Exp Pharmacol. 2005(168):1-51. doi: 10.1007/3-540-26573-2_1.
Zotero 插件